Table 3. Two models for predicting sustained off-treatment combined response at 48 weeks after EOT among HBeAg-positive chronic hepatitis B patients.

HBeAg-positive CHB patients
Factors	points
Model A
HBsAg <250 IU/mL	1
HBV DNA <2.5 × 107 IU/mL	1
Model B
HBsAg <250 IU/mL	2
HBV DNA <2.5 × 107 IU/mL	2
ALT ≥200 U/L	1

HBsAg, hepatitis B surface antigen; HBV, hepatitis B virus; ALT, alanine aminotransferase.